US2014079749A1PendingUtilityA1
Compositions and methods for improved skin care
Individually held — no corporate assignee on recordPriority: Oct 3, 2005Filed: Nov 15, 2013Published: Mar 20, 2014
Est. expiryOct 3, 2025(expired)· nominal 20-yr term from priority
Inventors:Mark A. Pinsky
A61P 17/16A61P 17/00A61P 15/18A61K 9/1272A61K 31/728A61K 38/39A61K 9/127A61Q 19/08A61K 8/735A61K 8/14A61K 9/0014A61Q 19/00A61K 8/65A61Q 19/04A61K 47/36A61K 47/42A61Q 19/02
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compositions and methods for administering collagen to a human subject have been developed. The collagen-containing lipid vesicles of the invention provide a delivery system for human collagen which eliminates problems associated with chemical and physical instability of the collagen as well as immune responses to non-human collagen.
Claims
exact text as granted — not AI-modifiedI claim:
1 . A liposome comprising hyaluronic acid.
2 . The liposome, according to claim 1 , wherein the hyaluronic acid is cross-linked.
3 . The liposome, according to claim 1 , further comprising collagen.
4 . The liposome, according to claim 1 , further comprising at least one of the group consisting of desquamation agents, anti-acne agents, anti-wrinkle agents, vitamin B 3 compounds, retinoids, hydroxyl acids, anti-oxidants, radical scavengers, chelators, flavonoids, anti-inflammatory agents, anti-cellulite agents, topical anesthetics, tanning agents, skin lightening agents, skin soothing and skin healing agents, antimicrobial and antifungal agents, sunscreen agents, conditioning agents, structuring agents, thickening agent, and preservatives.
5 . The liposome, according to claim 1 , which is paucilamellar.
6 . The liposome, according to claim 1 , which comprises non-phospholipid surfactants.
7 . A method for administering hyaluronic acid to the skin of a subject, the method comprising the step of contacting the skin of the subject with a composition comprising a carrier comprising a cavity having encapsulated therein hyaluronic acid.
8 . The method, according to claim 7 , wherein the hyaluronic acid is cross-linked.
9 . The method, according to claim 7 , wherein the liposome further comprises collagen.
10 . The method, according to claim 7 , wherein the liposome further comprises at least one of the group consisting of desquamation agents, anti-acne agents, anti-wrinkle agents, vitamin B 3 compounds, retinoids, hydroxyl acids, anti-oxidants, radical scavengers, chelators, flavonoids, anti-inflammatory agents, anti-cellulite agents, topical anesthetics, tanning agents, skin lightening agents, skin soothing and skin healing agents, antimicrobial and antifungal agents, sunscreen agents, conditioning agents, structuring agents, thickening agent, and preservatives.
11 . The method, according to claim 7 , wherein the liposome is paucilamellar.
12 . The method, according to claim 7 , wherein the liposome comprises non-phospholipid surfactants.Join the waitlist — get patent alerts
Track US2014079749A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.